BRIEF

on BASTIDE (EPA:BLC)

Finalization of the sale of EXPERF by Groupe Bastide to Sapio

Stock price chart of BASTIDE (EPA:BLC) showing fluctuations.

The Bastide Group has finalized the sale of New Medical Concept, the holding company of the EXPERF Group, to Sapio Group. The agreement, signed on May 21, 2026, will have its conditions precedent lifted at the end of the month. This move marks a step in Bastide's strategy, which aims to focus on high value-added segments.

Vincent Bastide, CEO of the group, emphasized the importance of this transaction in strengthening Bastide's financial structure. Sapio's CEO, Mario Paterlini, expressed his enthusiasm for the acquisition, which represents a key step in their European expansion.

EXPERF, a specialist in home infusion and nutrition, represents a strategic asset for Sapio, thanks to its network in France.

R. H.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all BASTIDE news